InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,070.55
(
1.20%
)
US TECH 100
17,138.80
(
0.80%
)
Dow Jones
38,503.69
(
0.00%
)
Brent Oil
87.32
(
-0.28%
)
Bitcoin
66,670.51
(
0.39%
)
Post# of 216
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

TREND1

Send PM Follow Ignore
Followers 417
Posts 52354
Boards Moderated 13
Alias Born 12/16/2001

TREND1

Member Level

Re: None

Monday, 10/09/2017 10:24:58 AM

Monday, October 09, 2017 10:24:58 AM

Post# of 216
10/9 MannKind: Rise On Affreza Label Revision Acceptance

•Afreezza script sales rise to over 440.

•Script sales for the quarter come in at nearly 4,900.

•Stock has risen sharply on FDA acceptance of label revision


https://seekingalpha.com/article/4112400-mannkind-afrezza-sales-rise-along-stock-price?auth_param=1vat:1ctmrsu:5f5b5991d1659bdb2daf89591a41866a&uprof=51#alt3

TRADING 01 LIST https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133836402

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up